Steris PLC (NYSE:STE)

$ 208.68 0.68 (0.33%) Market Cap: 20.53 Bil Enterprise Value: 22.73 Bil PE Ratio: 47.49 PB Ratio: 3.11 GF Score: 92/100

Q2 2025 STERIS plc Earnings Call Transcript
Nov 07, 2024

$215.5 (-5.28%)

Earnings
Q1 2025 STERIS plc Earnings Call Transcript
Aug 07, 2024

$233.53 (-2.36%)

Earnings
Q3 2024 STERIS plc Earnings Call Transcript
Feb 08, 2024

$220.26 (-2.48%)

Earnings
Q2 2024 STERIS plc Earnings Call Transcript
Nov 08, 2023

$206.32 (-5.46%)

Earnings
STERIS plc at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2023
Q1 2024 STERIS plc Earnings Call Transcript
Aug 02, 2023

$227.8 (+1.69%)

Earnings
Q4 2023 STERIS plc Earnings Call Transcript
May 11, 2023

$208 (+9.83%)

Earnings
Q3 2023 STERIS plc Earnings Call Transcript
Feb 09, 2023

$192.34 (-10.89%)

Earnings
Q2 2023 STERIS plc Earnings Call Transcript
Nov 10, 2022

$169.27 (+5.15%)

Earnings
Q1 2023 STERIS plc Earnings Call Transcript
Aug 03, 2022

$203 (-9.55%)

Earnings
Q4 2022 STERIS plc Earnings Call Transcript
May 12, 2022

$218.39 (+2.74%)

Earnings
Q3 2022 STERIS plc Earnings Call Transcript
Feb 09, 2022

$237.35 (+2.89%)

Earnings
Q2 2022 Steris plc Earnings Call Transcript
Nov 03, 2021

$222.72 (-5.92%)

Earnings
Q1 2022 Steris plc Earnings Call Transcript
Aug 10, 2021

$217.62 (+1.21%)

Earnings
Q4 2021 Steris plc Earnings Call Transcript
May 19, 2021

$189.4 (-3.34%)

Earnings
Q3 2021 Steris plc Earnings Call Transcript
Feb 03, 2021

$182.87 (-4.30%)

Earnings
Steris plc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 13, 2021
Steris plc to Acquire Cantel Medical Corp - M&A Call Transcript
Jan 12, 2021
Steris plc at Needham Virtual Growth Conference Transcript
Jan 11, 2021
Q2 2021 Steris plc Earnings Call Transcript
Nov 03, 2020

$176.38 (-2.86%)

Earnings
Steris plc Management Call -- Key Surgical Acquisition Transcript
Oct 06, 2020
Q1 2021 Steris plc Earnings Call Transcript
Aug 04, 2020

$158 (-1.91%)

Earnings
Steris plc Annual Shareholders Meeting Transcript
Jul 28, 2020
Q4 2020 Steris plc Earnings Call Transcript
May 14, 2020

$150.89 (+2.60%)

Earnings
Steris plc at Raymond James Institutional Investors Conference Transcript
Mar 02, 2020
Q3 2020 Steris plc Earnings Call Transcript
Feb 11, 2020

$162.27 (+5.45%)

Earnings
Q2 2020 Steris plc Earnings Call Transcript
Nov 05, 2019

$145.48 (+3.52%)

Earnings
Steris plc at Morgan Stanley Healthcare Conference Transcript
Sep 10, 2019
Q1 2020 Steris plc Earnings Call Transcript
Aug 06, 2019

$152.32 (+5.33%)

Earnings
Q4 2019 Steris plc Earnings Call Transcript
May 14, 2019

$130.64 (+4.45%)

Earnings
STERIS plc at Raymond James Institutional Investors Conference Transcript
Mar 04, 2019
Q3 2019 STERIS plc Earnings Call Transcript
Feb 12, 2019

$120.8 (+0.78%)

Earnings

Q1 2025 STERIS plc Earnings Call Transcript

Aug 07, 2024 / 01:00PM GMT

Release Date Price: $233.53 (-2.36%)

Transcript 10-Q8-K

Operator

Good morning and welcome to the STERIS first-quarter of 2025 earnings call. (Operator Instructions) Also, please be aware that today's call is being recorded.

I would like to now turn the call over to Julie Winter of Investor Relations. Please go ahead.

Julie Winter

STERIS PLC - VP of IR & Corporate Communications

Thank you, Joe. And good morning, everyone. As usual, speaking on today's call will be Mike Tokich, our Senior Vice President and CFO; and Dan Carestio, our President and CEO. I do have a few words of caution before we open for comments. This webcast contains time-sensitive information that is accurate only as of today. Any redistribution, retransmission, or rebroadcast of this call without the expressed written consent of STERIS is strictly prohibited.

Some of the statements made during this review are or may be considered forward-looking statements. Many important factors could cause actual results to differ materially from those in the forward-looking statements, including without limitation, those risk factors described in

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.